Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-02-22

Clinical Trial Update: Green Tea and Reduction of Breast Cancer Risk [Phase 2]

View source ↗

Summary

Phase 2 clinical trial assessing whether green tea consumption reduces breast cancer risk; the study is completed and results were posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Minnesota | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2016-02-22